IL-6, IL-8, IL-18, IL-1β, TNF-α, and CRP levels were significantly increased in T2D patients with poor glycemic control (>8% HbA1c) compared to patients with moderate glycemic control (>7-8% HbA1c). The gene discussed is IL18; the disease is type 2 diabetes mellitus.